相关实验视频
Updated: Jun 29, 2026

18:25
Orthotopic Liver Transplantation in Rats
Published on: July 1, 2012
30.1K
肝移植中的 ангиотензин II (AngLT-1): 随机,双盲,安慰剂对照试验的协议
Michael P Bokoch1, Amy T Tran2, Erika L Brinson2
1Department of Anesthesia and Perioperative Care, University of California San Francisco, San Francisco, California, USA Michael.Bokoch@ucsf.edu.
BMJ open
|November 20, 2023
概括
这项研究评估了血管素II作为肝移植患者的二线血管压缩剂. 它的目的是降低北上腺素剂量,潜在地改善器官 perfusion 和降低损伤风险.
科学领域:
- 移植医学 移植医学
- 心血管药理学心血管药理学
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 像诺阿基尼林这样的甲基荷胺是肝移植期间血压的标准.
- 高剂量的甲基甲醇胺可能会损害器官输液.
- ангиотензин II 可能改善 perfusion 和减少急性损伤.
研究的目的:
- 评估血管素II作为肝移植中的二线血管压缩剂的疗效.
- 为了确定血管素II是否可以降低诺尔上腺素剂量,同时保持足够的血压.
- 为未来关于器官损伤减少的试验提供信息.
主要方法:
- 双盲,随机的临床试验.双盲,随机的临床试验.
- 患有MELD-Na≥25的成年人接受肝移植,随机分配给血管新素II或安慰剂.
- 主要结局:以保持平均动脉压≥65毫米升的剂量维持诺阿皮内弗林的剂量.
主要成果:
- 维持目标血压所需的诺尔上腺素剂量是主要结果.
- 二次结局包括血管压素/上腺素使用和低血压持续时间.
- 安全结果侧重于血栓栓塞和严重高血压.
结论:
- ангиотензин II 在肝移植中显示出作为替代血管压缩剂的潜力.
- 需要进一步的研究来证实其对器官输液和损伤的益处.
- 这项试验为更大规模的多中心研究提供了基础.
相关概念视频
Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...

